CORALVILLE, Iowa, April 30, 2010 (GLOBE NEWSWIRE) -- Vivakor, Inc. (OTCBB:VIVK) announced new markets for its VivaThermic technologies and further increased revenue projections for its VivaThermic division. These new markets include gene amplification applications and similar uses where temperature control is especially critical. Speaking about these new genetic applications, Dr. Tannin Fuja, Vivakor's CEO and Chief Scientific Officer, said, "Thermo-cycling and other temperature sensitive reactions have become common in nearly every biological laboratory. VivaThermic products improve temperature control of these reactions and will improve sensitivity and save time."
Additionally, VivaThermic technologies are being marketed as the best bio-consumable container for biological and stem cell related reagents which must be stored in temperature controlled environments. Dr. Fuja stated, "The global market of consumables for temperature sensitive reagent shipment, handling and storage is already enormous and continues to grow." This announcement will expand upon Vivakor's recently released revenue projections for its VivaThermic division estimated at $20 million annually.
About Vivakor, Inc.
Vivakor™ is a biomedical/biotechnology company with transdisciplinary research that develops and acquires products in the fields of molecular medicine, electro-optics, biological handling and natural and formulary compounds that extend or improve life. More information can be found about Vivakor at www.vivakor.com.
FORWARD-LOOKING STATEMENTS
This press release may contain forward-looking statements, including, but not limited to, statements regarding Vivakor's products and their related market potential. Forward-looking statements may be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, risks and uncertainties discussed in Vivakor's filings with the Securities and Exchange Commission, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. Vivakor undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this press release or to reflect actual outcomes.